Abstract
Objectives
To study the structure of a small GTPaseRhoA in complex with PDZRhoGEF and the inhibitor HL47, and to provide an easier template for R&D of RhoA inhibitor.
Results
Our initial attempts to obtain a binary complex of RhoA with the inhibitor HL47 were unsuccessful probably due to the presence of GDP. By targeting a ternary complex involving the RhoA-specific guanine nucleotide exchange factor PDZRhoGEF, we eliminated GDP and obtained a 2.3 Å structure of the RhoA-PDZRhoGEF-inhibitor HL47 ternary complex.
Conclusion
This structure provides a new template for target-based pharmaceutical design against RhoA.
Similar content being viewed by others
References
Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308–1311
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98:10037–10041
Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) Acta Cryst D66:12–21
Collaborative Computational Project, Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Cryst D50:760–763
D’Arcy A, Bergfors T, Cowan-Jacob SW, Marsh M (2014) Microseed matrix screening for optimization in protein crystallization: what have we learned. Acta Cryst F70:1117–1126
DeLano WL (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, USA. http://www.pymol.org
Deng J, Feng EG, Ma S, Zhang Y, Liu XF, Li HL, Huang H, Zhu J, Zhu WL, Xu S, Miao LY, Liu H, Jiang HL, Li J (2011) Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases. J Med Chem 54:4508–4822
Derewenda U, Oleksy A, Stevenson AS, Korczynska J, Dauter Z, Somlyo AP, Otlewski J, Somlyo AV, Derewenda ZS (2004) The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle. Structure 12:1955–1965
Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Cryst D66:486–501
Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629–635
Gamblin SJ, Smerdon SJ (1998) GTPase-activating proteins and their complexes. Curr Opin Struct Biol 8:195–201
Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9:690–701
Ihara K, Muraguchi S, Kato M, Shimizu T, Shirakawa M, Kuroda S, Kaibuchi K, Hakoshima T (1998) Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem 273:9656–9666
Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269
Kaibuchi K, Kuroda S, Amano M (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68:459–486
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemicai quality of protein structures. J Appl Cryst 26:283–291
Li DB, Yang GJ, Xu HW, Fu ZX, Wang SW, Hu SJ (2013) Regulation on RhoA in vascular smooth muscle cells under inflammatory stimulation proposes a novel mechanism mediating the multiple-beneficial action of acetylsalicylic acid. Inflammation 36:1403–1414
Ma S, Deng J, Li BL, Li XJ, Yan ZW, Zhu J, Chen G, Wang Z, Jiang HL, Miao LY, Li J (2015) Development of second-generation small-molecule RhoA inhibitors with enhanced water solubility, tissue potency, and significant in vivo efficacy. Chem Med Chem 10:193–206
Madaule P, Axel R (1985) A novel ras-related gene family. Cell 41:31–40
Matthews BW (1968) Solvent content of protein crystals. J Mol Biol 33:491–497
McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40:658–674
Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) Acta Cryst D67:355–367
Narumiya S (1996) The small GTPase Rho: cellular functions and signal transduction. J Biochem 120:215–228
Takai Y, Sasaki T, Tanaka K, Nakanishi H (1995) Rho as a regulator of the cytoskeleton. Trends Biochem Sci 20:227–231
Vagin A, Teplyakov A (2010) Molecular replacement with MOLREP. Acta Cryst D66:22–25
Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, McCoy A, McNicholas SJ, Murshudov GN, Pannu NS, Potterton EA, Powell HR, Read RJ, Vagin A, Wilson KS (2011) Acta Cryst D67:235–242
Yin Y, Lin L, Ruiz C, Khan S, Cameron MD, Grant W, Pocas J, Eid N, Park H, Schroter T (2013) Synthesis and biological evaluation of urea derivatives as highly potent and selective rho kinase inhibitors. J Med Chem 56:3568–3581
Zhang Y, Deng J, Ma S, Xue L, Zhu J, Zhu WL, Jiang HL, Li J, Miao LY (2012) The effect of first-in-class small molecule RhoA inhibitor, HL07, on the phenylephrine-induced artery contraction. Curr Pharm Des 27:4258–4264
Acknowledgements
The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (Grant Nos. 81202394, 21222211, 21372001 and 91313303), the Ministry of Education of China’s Program for New Century Excellent Talents in University (Grant No. NCET-12-0853), the Young Medical Talents Project of Jiangsu Province, and the Applied Basic Research Programs of Suzhou Sci-tech Bureau, China (Grant No. SYS201219).
Supporting information
Supplementary Table 1—Macromolecule production data for RhoA and PDZRhoGEF.
Supplementary Table 2—Crystallization information.
Supplementary Table 3—Data collection and processing.
Supplementary Table 4—Structure refinement.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Zhaowei Yan and Sheng Ma have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yan, Z., Ma, S., Zhang, Y. et al. The structure of a small GTPaseRhoA in complex with PDZRhoGEF and the inhibitor HL47. Biotechnol Lett 39, 745–750 (2017). https://doi.org/10.1007/s10529-017-2292-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-017-2292-7